Home › Targets › BAFF

BAFF (2 companies · 9 programs)

Companies with an active program directed at BAFF.

Vera Therapeutics, Inc. VERA

atacicept — IgA Nephropathy NDA Submitted
atacicept — Primary Membranous Nephropathy Phase 2
atacicept — Focal Segmental Glomerulosclerosis Phase 2
atacicept — Minimal Change Disease Phase 2
VT-109 Preclinical
VT-109 Preclinical
atacicept — Membranous Nephropathy Phase 2

Vor Biopharma Inc. VOR

telitacicept — Generalized Myasthenia Gravis Phase 3
telitacicept — Sjögren's Disease Phase 3